???? ???????????? ???????? ????????????????????????: ???? ?????? ???????? ???? ?????????? ????????????
Koushik Mukherjee, PhD
Assistant Professor, Department of Microbiology, Kalyani Mahavidyalaya
?????????????? ??????????????????, ????. ??.
?????????????????? ??????????????????, ????????????????????????
?????????????? ??????????????????????????, ??????????????, ??????????, ????
The pandemic has educated us with a bunch of new terminologies with the addition of black fungus in the new terror list. First of all, these demons have always been resided in microbiology textbooks and acted like a terror for Microbiology students like us. So, they are nothing new. There are Zillions of virus, bacteria, fungi, parasites around to nail us to death. They were always there in textbooks, research papers, clinical notes, it’s just that the pandemic has brought them to newspapers and TV channels. Thanks to mother nature and our immune system that we are still alive even with a co-existence with them. Once the immune mechanism is compromised we become prey to those microscopic demons.
*???? ?????? ?????? ?????? ????????*
However, the preface is just to clear confusion about the overlap of two terminologies in news these days. The term Black fungus disease and mucormycosis are being used interchangeably in popular articles and media. *??????????????????????????, ?????????? ?????? ?????? ???? ???????????????? ?????????????????? ?????????????? ???????? ???????????? ???????? ???????????????????????? ???? ?????? ?????????????????????????????? ?????? ????????????????????????.* The prominent point that misguided us is their ability to attack immunocompromised patients at more or less similar target organs as in the case of COVID-19 infection. ????????????????, ???? ???????????????????? ???????????????????? ?????? ?????????????????? ?????? ???????? “ ?????????? ????????????” ?????????? ???????????????????? ???????????????? ???? ???????????????????????? ?????? ???????? ??????????. Let us have a quick look at some dissimilarity of these two diseases:
*?????????????????? ?????????????????????? ????????????*
Black fungi or sometimes known as black yeasts fall into the class of Dematiaceous fungi that are responsible for a wide variety of infectious syndromes. They are often found in soil and rotten plant materials and generally inhaled by most if not all individuals. However, its pathogenicity becomes significant in immunocompromised individuals.
The clinical nomenclatures caused by these black fungi are mycetoma, chromoblastomycosis, and phaeohyphomycosis, and NOT mucormycosis which is of entirely different origin. The causative genera for these clinical manifestations are ?????????????????? ????????????????????????, ????????????????????????????????-, ??????????????????- ?????? ????????????????????????????-like strains, known in humans as agents of chromoblastomycosis.
On the other hand, the causative agents for mucormycosis are certain fungi, especially Rhizopus and mucormycetes, which are common contaminants of laboratory cultures. Some of the fungi that are responsible for mucormycosis are ???????????????? ??????????????, ?????????? ??????????????, ???????????????????? ??????????????, ?????????????????????????????? ??????????????, ???????????????????????????? ??????????????????????????, ?????????????????????????? ??????????????, ?????? ?????????????????????? (???????????????? ??????????????) ??????????????.
*???????? ???? ?????????? ???? ????*
At this point, this is clear that the causative agents are completely different for these two types of diseases. Let us take a break from finding the differences between these two clinical manifestations and concentrate on a more interesting question.
*Why these Dematiaceous fungi are called “BLACK” fungus?*
Interestingly, these fungi possess unique pathogenic mechanisms attributed to the presence of melanin in their cell walls, which imparts the characteristic dark color to their spores and hyphae. On contrary, no such characteristic features are consistently prominent in the microscopic observation of all fungal species that are mucormycosis-causing organisms. Of note, Mucormycosis causes tissue blackening by devitalizing its blood supply, and this black appearance has been misinterpreted, misreported, and misdiagnosed as a black fungus by the media.
*???? ?????? ???? ?????? ?????????? ????????*
Fortunately, despite the confusing terminology, our able physicians have detected the correct disease in COVID-affected individuals- it is Mucormycosis NOT anything caused by black fungus. Therefore, they are predominantly treated by IV amphotericin B and some azoles. Of note, itraconazole and voriconazole demonstrate the most consistent in vitro activity against black fungi (except S. prolificans, which are resistant to azoles) whereas voriconazole is completely ineffective in mucormycosis. Whereas, fluconazole and echinocandins exhibit limited or no activity against both types of diseases.
There are many other similarities in the pathogenesis and presentation that lead to the overlap of the terminologies. Sources for both the etiological agents are the same: soil, composts, rotten woods, decaying organic matter. Mucormycosis has rhinocerebral, ocular, pulmonary, gastrointestinal, involvements. The black fungus affects similar organs with less severity than mucormycosis. Mucormycosis is a more morbid condition than in diseases involving black fungus. It often requires multiple surgeries even involving enucleation (Complete removal of the eye).
*?????????? ??????????*
I am not discussing the co-morbidities that trigger the mucormycosis infection as it is now a well-known topic. Just to mention that there is no scientific evidence that oxygen pipes, oxygen flowmeter, or humidifier are responsible for its spread or origin. Unlike Covid-19, it is not contagious and does not spread from one person to another. Finally, the causative agents are co-existing with us in nature and it is not going to be fatal to you unless you are being treated with high steroids and your diabetes is not under control during your COVID infections days.
????????????????????
Baker, R. D. (1957). Mucormycosis—a new disease?. Journal of the American Medical Association, 163(10), 805-808.
Baker R.D. (1971) Mucormycosis. In: The Pathologic Anatomy of Mycoses. Handbuch der Speziellen Pathologischen Anatomie und Histologie (Atmungswege und Lungen), vol 3 / 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80570-7_22
Hoog, G. S. de, Queiroz-Telles, F., Haase, G., Fernandez-Zeppenfeldt, G., Angelis, D. A., H. G. Gerrits van den Ende, A., … Yegres, F. (2000). Black fungi: clinical and pathogenic approaches. Medical Mycology, 38(s1), 243–250. doi:10.1080/mmy.38.s1.243.250
McGinnis MR, Hilger AE. Infections Caused by Black Fungi. Arch Dermatol. 1987;123(10):1300–1302. doi:10.1001/archderm.1987.01660340062020
https://www.cdc.gov/fungal/diseases/mucormycosis/treatment.html
Revankar SG. Dematiaceous fungi. Mycoses. 2007 Mar;50(2):91-101. doi: 10.1111/j.1439-0507.2006.01331.x. PMID: 17305771.
Head of Quality, Tata Chemicals Ltd. Nutritional Business (NQ) Divsion.
3 年Nicely explained Dr Koushik..
An Assistant Professor with 14 years of research experience in Food Science and Technology, Chromatography, Method development, product development etc.. Reviewer-Journal of Food Science and Technology
3 年good, very informative....
asstt professor at tarakeswar degree college
3 年Very effective initiative at this juncture
Associate Professor, Department of Biotechnology, The Neotia University
3 年Excellent
Biopharmaceuticals Probiotics Enzymes|Preclinical & clinical|Process & Quality|Regulatory|Project management
3 年Very well written!